Novartis AG NOVARTIS ORD SHS | 79.35 / -0.33% |
Date/Time | 02/25 / 15:34 |
Chg. / Chg.(%) | -0.26 / -0.33% |
Bid | 77.30 / 5000 |
Ask | 81.26 / 5000 |
Open | 78.70 |
Previous Close | 79.61 |
High | 79.65 |
Low | 78.81 |
Volume [CHF] | 71,617,316.37 |
Volume [Units] | 2,903,568 |
Price fixings | 161 |
ISIN | CH0012005267 |
Security | 0QLR |
Exchange | London International |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
London Inter.. | 79.35 | ![]() |
2,903,568 |
SIX Swiss Ex.. | 79.29 | ![]() |
2,440,877 |
Cboe Europe .. | 79.30 | ![]() |
203,645 |
Cboe Europe .. | 79.29 | ![]() |
141,763 |
Turquoise | 79.30 | ![]() |
65,609 |
Lang & Schwa.. | 71.340 | ![]() |
|
Nasdaq Other.. | 85.8000 | 2,716 | |
TradeGate | 80.000 | 16,350 | |
Frankfurt | 80.1600 | 1,589 | |
Borsa Italia.. | 79.20 | 1,042 | |
Hamburg | 80.19 | 1,000 | |
München | 80.10 | 55 | |
Berlin | 80.40 | 40 | |
gettex | 80.160 | 20 | |
Düsseldorf | 80.18 | 4 | |
Hannover | 80.10 | 0 | |
Borsa Italia.. | 75.00 | 36 | |
EUREX | Options |
News
- Cue Biopharma Enhances Scientific Advisory Board with Appointments of Immunology and Immunotherapy Experts Dr. Abul K. Abbas and Dr. Michael Kalos
14:00 - GlobeNewswire - Intellia Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results
13:30 - GlobeNewswire - Novartis Entresto® granted expanded indication in chronic heart failure by FDA
02/16/2021 / 19:22 - GlobeNewswire - Novartis signs initial deal to manufacture Pfizer jabs
01/29/2021 / 13:04 - TeleTrader - Novartis Sees 6-Figure Savings with Qlik
01/26/2021 / 14:30 - GlobeNewswire